Emily Robinson
- Oncology top 5%
- Molecular Biology
- Genetics top 10%
- Biomedical Engineering
- Immunology top 10%
- Co-authors
- Colette ChaneyShelly HeimfeldCarolina BergerStanley R. RiddellLaïla‐Aïcha HanafiSindhu CherianBarbara PenderLorinda Soma
- Topics
- CAR-T cell therapy research (3 papers)Substance Abuse Treatment and Outcomes (2 papers)Alcohol Consumption and Health Effects (2 papers)
- Cited by
- OncologyImmunologyGenetics
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Emily Robinson
12 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Oncology 814
- Molecular Biology 298
- Genetics 267
- Biomedical Engineering 240
- Immunology 218
Countries citing papers authored by Emily Robinson
This map shows the geographic impact of Emily Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Robinson more than expected).
Fields of papers citing papers by Emily Robinson
This network shows the impact of papers produced by Emily Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Robinson. The network helps show where Emily Robinson may publish in the future.
Co-authorship network of co-authors of Emily Robinson
This figure shows the co-authorship network connecting the top 25 collaborators of Emily Robinson. A scholar is included among the top collaborators of Emily Robinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Robinson. Emily Robinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 11 | |
| 5 | 7 | |
| 6 | 1 | |
| 7 | 23 | |
| 8 | Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 + and CD4 + CD19-specific chimeric antigen receptor–modified T cellsbreakdown → | 741 |
| 9 | 44 | |
| 10 | 59 | |
| 11 | 42 | |
| 12 | 93 | |
| 13 | 12 |
About Emily Robinson
Emily Robinson is a scholar working on Transplantation, Otorhinolaryngology and Applied Psychology, having authored 13 papers that have together received 1.0k indexed citations. Recurring topics across this work include CAR-T cell therapy research (3 papers), Substance Abuse Treatment and Outcomes (2 papers) and Alcohol Consumption and Health Effects (2 papers). The work is most often cited by research in Oncology (814 citations), Immunology (218 citations) and Genetics (267 citations). Emily Robinson has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Colette Chaney, Shelly Heimfeld, Carolina Berger, Stanley R. Riddell, Laïla‐Aïcha Hanafi, Sindhu Cherian, Barbara Pender, Lorinda Soma, David G. Maloney and Cameron J. Turtle. Their work appears in journals such as Blood, Science Translational Medicine and Health Psychology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.